Product Images Up And Up Mini Nicotine Polacrilex

View Photos of Packaging, Labels & Appearance

Product Label Images

The following image provide visual information about the product associated with Up And Up Mini Nicotine Polacrilex NDC 11673-881 by Target Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

6u4-uw-mini-nicotine-lozenge - image 01

6u4-uw-mini-nicotine-lozenge - image 01

This is a product information sheet on Nicotine Polacrilex Lozenge, a stop smoking aid containing 4 mg of nicotine. The lozenge helps to reduce withdrawal symptoms associated with quitting smoking, including cravings. The text highlights the active ingredients, precautions, dosage advice, and inactive ingredients used in the lozenge. The sheet cautions users to seek medical advice before use if pregnant, asthmatic, diabetic, or suffering from seizures, among others. The recommended use includes following a 12-week schedule for maximum results, while it is advised not to exceed 20 lozenges per day. The sheet also urges individuals not to use the lozenge continuously or in combination with other medications, including prescription or non-prescription drugs. If any side effects such as hiccups, irregular heartbeat, or allergic reactions occur, it's advised to stop using the product immediately and consult with a healthcare professional. The sheet also emphasizes the importance of completing the recommended treatment for long-term success in quitting smoking and keeping the product out of reach of children and pets due to potential adverse effects.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.